Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Moodys
AstraZeneca
Accenture
McKinsey
US Department of Justice
Teva
Express Scripts
Queensland Health

Generated: October 23, 2017

DrugPatentWatch Database Preview

LUZU Drug Profile

« Back to Dashboard

What is the patent landscape for Luzu, and what generic Luzu alternatives are available?

Luzu is a drug marketed by Medicis and is included in one NDA. There are five patents protecting this drug.

This drug has sixty-four patent family members in twenty-five countries.

The generic ingredient in LUZU is luliconazole. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the luliconazole profile page.

Summary for Tradename: LUZU

US Patents:5
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list30
Patent Applications: see list22
Drug Prices:see details
DailyMed Link:LUZU at DailyMed

Pharmacology for Tradename: LUZU

Ingredient-typeAzoles
Drug ClassAzole Antifungal
Mechanism of ActionCytochrome P450 2C19 Inhibitors
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Medicis
LUZU
luliconazole
CREAM;TOPICAL204153-001Nov 14, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: LUZU

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,085,554Method of evaluating pharmaceutical preparation containing luliconazole and index substance► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: LUZU

Country Document Number Estimated Expiration
New Zealand311796► Subscribe
Austria407832► Subscribe
Switzerland692045► Subscribe
Japan2014172858► Subscribe
World Intellectual Property Organization (WIPO)2014136282► Subscribe
Japan5589110► Subscribe
Sweden9800016► Subscribe
China105026390► Subscribe
China104284662► Subscribe
Mexico9710401► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Army
Argus Health
McKinsey
AstraZeneca
US Department of Justice
Mallinckrodt
Baxter
Federal Trade Commission
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot